News

Rare kidney cancer resists immune therapies due to lack of active T-cells
Cancer-fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal ...
Fierce Biotech5d
ProKidney’s CKD cell therapy scores win in one half of phase 2 trial, falls short on other
At one point, ProKidney had been running an international phase 3 trial, dubbed PROACT 2, of rilparencel alongside the ...
Mirage News10d
Breakthrough in Chromophobe Renal Cancer Treatment
Cancer fighting T-cells, the immune system's primary enforcers, are scarce in the rare kidney cancer called chromophobe renal cell ...